Literature DB >> 8270868

Membrane interactions influence the peptide binding behavior of DR1.

M A Sherman1, H A Runnels, J C Moore, L J Stern, P E Jensen.   

Abstract

We analyzed the binding of an influenza matrix protein-derived peptide, MAT(17-31), to cell surface and purified DR1. The pH dependence of peptide binding was dramatically influenced by the membrane environment. Cell surface binding was enhanced at low pH, with little or no binding detected at neutral pH and optimal binding at pH 4. By contrast, hydrogen ion concentration had minimal effect on peptide binding to purified DR1. Exposure to low pH in the absence of peptide did not affect the peptide binding capacity of cell-associated DR1. Purified DR1 was stable at low pH, excluding the possibility that enhanced binding was offset by a competing denaturation event at low pH. The striking effect of pH on peptide binding characteristic of cell surface DR1 was recovered after reconstitution of purified DR1 in B cell membranes by detergent dialysis. This behavior was partially recovered by reconstitution of full-length, but not truncated DR1 in vesicles containing purified lipid. Our results demonstrate that interactions involving membrane components influence the peptide-binding behavior of DR1.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8270868      PMCID: PMC2191328          DOI: 10.1084/jem.179.1.229

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  28 in total

1.  The human class II MHC protein HLA-DR1 assembles as empty alpha beta heterodimers in the absence of antigenic peptide.

Authors:  L J Stern; D C Wiley
Journal:  Cell       Date:  1992-02-07       Impact factor: 41.582

2.  Structural intermediates in the reactions of antigenic peptides with MHC molecules.

Authors:  K Dornmair; B Rothenhäusler; H M McConnell
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1989

3.  Purification and characterization of class II histocompatibility antigens from a homozygous human B cell line.

Authors:  J C Gorga; V Horejsí; D R Johnson; R Raghupathy; J L Strominger
Journal:  J Biol Chem       Date:  1987-11-25       Impact factor: 5.157

4.  A kinetic intermediate in the reaction of an antigenic peptide and I-Ek.

Authors:  S Sadegh-Nasseri; H M McConnell
Journal:  Nature       Date:  1989-01-19       Impact factor: 49.962

5.  Stable association of processed antigen with antigen-presenting cell membranes.

Authors:  P E Jensen
Journal:  J Immunol       Date:  1989-07-15       Impact factor: 5.422

6.  Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis.

Authors:  A Sette; S Buus; E Appella; J A Smith; R Chesnut; C Miles; S M Colon; H M Grey
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

7.  Structural model of HLA-DR1 restricted T cell antigen recognition.

Authors:  J B Rothbard; R I Lechler; K Howland; V Bal; D D Eckels; R Sekaly; E O Long; W R Taylor; J R Lamb
Journal:  Cell       Date:  1988-02-26       Impact factor: 41.582

8.  Co-fluorescence of europium and samarium in time-resolved fluorimetric immunoassays.

Authors:  Y Y Xu; I Hemmilä; V M Mukkala; S Holttinen; T Lövgren
Journal:  Analyst       Date:  1991-11       Impact factor: 4.616

9.  Phospholipids enhance the binding of peptides to class II major histocompatibility molecules.

Authors:  R W Roof; I F Luescher; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

10.  Regulation of antigen presentation by acidic pH.

Authors:  P E Jensen
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

View more
  4 in total

Review 1.  HLA-DM and the MHC class II antigen presentation pathway.

Authors:  P E Jensen; D A Weber; W P Thayer; X Chen; C T Dao
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Processing of the DRB1*1103-restricted measles virus nucleoprotein determinant 185-199 in the endosomal compartment.

Authors:  S Demotz; W Ammerlaan; P Fournier; C P Muller; C Barbey
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

3.  An insulin peptide that binds an alternative site in class II major histocompatibility complex.

Authors:  S M Tompkins; J C Moore; P E Jensen
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

4.  Phase coexistence in single-lipid membranes induced by buffering agents.

Authors:  Merrell A Johnson; Soenke Seifert; Horia I Petrache; Ann C Kimble-Hill
Journal:  Langmuir       Date:  2014-08-13       Impact factor: 3.882

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.